Drug search by name

Fycompa (Perampanel Oral Suspension) and Hepatic impairment

Result of checking the interaction of drug Fycompa (Perampanel Oral Suspension) and disease Hepatic impairment for safety when used together.

Check result:

Fycompa (Perampanel Oral Suspension) <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of perampanel in patients with severe hepatic impairment is not recommended. Dosage adjustments are recommended in patients with mild or moderate hepatic impairment as the half-life of perampanel may increase in these patients. Care should be exercised when prescribing this agent to patients with hepatic impairment, and close monitoring of liver function is recommended.

Fycompa (Perampanel Oral Suspension)

Generic Name: perampanel

Brand Name: Fycompa

Synonyms: Fycompa

What is Fycompa (Perampanel Oral Suspension)?